Skip to main content

Table 3 Multivariate logistic regression on risk of recurrence from 2011 to 2016 (n = 1362)

From: A clinical tool to predict Plasmodium vivax recurrence in Malaysia

Characteristic (reference)

Beta

Odds Ratio

95% CI

P-value

Score

Age (≥ 27 years)

 Less than 27 years

0.66

1.93

1.07

3.51

0.03

1

Gametocyte (<80 parasite/μL)

  ≥ 80 parasite/μL

1.53

4.60

1.06

19.84

0.04

2

Malaria transmission type (Non-indigenous)

 Indigenous

0.88

2.42

1.03

5.69

0.04

1

Treatment type (ACT plus PQ)

 CP plus PQ

0.96

2.61

0.78

8.74

0.12

2

Status of treatment (Complete)

 Incomplete

1.29

4.48

0.89

20.02

0.14

2

Total score

     

8

  1. ACT Artemisinin-based combination therapies, CP Chloroquine, PQ Primaquine